Strategic Evidence & Value Communication Symposium
Join us on 2021 年 4 月 21 日, 星期三, from12:00 PM – 2:00 PM EDT for Certara’s…
Certara2021 年 3 月 26 日
Purity is a Virtue: A Practical Guide to the Reporting of Impurities
Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…
Certara2021 年 3 月 23 日
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
The extent of cross-protection provided by currently licensed bivalent and quadrivalent HPV vaccines versus direct…
Certara2021 年 3 月 18 日
Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?
By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect…
Certara2021 年 3 月 10 日
PK Submit CDISC Technology
PK Submit automates the time consuming, error-prone and complex task of creating CDISC domains as…
Certara2021 年 3 月 10 日
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations
• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…
Certara2021 年 3 月 10 日
Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors
It is crucial for biotech developers to engage in early commercial market assessment to generate…
Certara2021 年 3 月 5 日
